Delivery Order SPE2DB20D3505-SPE2DB25FT9X0
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,857.91 firm-fixed-price Delivery Order contract is for the supply of PROLENSA 0.07% eye drops, a prescription ophthalmic medication. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,455.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560410185 PROLENSA 0.07% eye drops, a specialty pharmaceutical product, with a period of performance through March 29, 2023. This delivery order is under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,998.10, covers the delivery of PROLENSA 0.07% eye drops (3ml) and has a completion date of September 12, 2023. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,258,236 units of PROLENSA 0.07% eye drops. The Firm Fixed Price delivery order, valued at $4,319.98, has a period of performance through March 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,555,355,594 units of PROLENSA 0.07% eye drops in 3 milliliter vials. The firm-fixed-price delivery order, valued at $16,328.27, has a period of performance through November 9, 2021. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of PROLENSA 0.07% eye drops, a specialty pharmaceutical product, with a ceiling value of $1,261.70. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is October 11, 2023. The contract award is not associated with...
The federal contract award is for the delivery of PROLENSA 0.07% eye drops, 3ml, to the Defense Logistics Agency (DLA). The $2,031.44 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 12, 2024, with a completion date of July 15, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $2,670.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of PROLENSA 0.07% eye drops in 3mL quantities, with a completion date of November 4, 2024. The award is a firm-fixed price delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROLENSA 0.07% eye drops. The firm-fixed-price contract, valued at $3,039.35, has a period of performance through July 10, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of PROLENSA 0.07% eye drops (3ml) to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 26, 2023, with a total ceiling value of $19,398.20 and a completion date of September 27, 2023. The contract is a delivery order with a firm fixed-price pricing type. This contract is not...